HopeStage
Back to all studies
CompletedNCT04126135

Cytisine or Nicotine Replacement to Support Smoking Cessation

About this titleRead the official source — NCT04126135
Medication studyAges 18–100MongoliaAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 100 years.

Listed locations
UlaanbaatarSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 27, 2022
Recruitment status
Completed
Enrollment listed in the registry
1,307
Sponsor
Loma Linda University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Mongolia
Age range
From 18 Years to 100 Years
Official registry ID
NCT04126135
Official title
Show the full official title

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy (NRT) in the National Smoking Cessation Program of Mongolia: A Pragmatic Non-Inferiority Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Ulaanbaatar

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Loma Linda University, a university.

Did this study involve medication?

Yes. The study involved medication, including Cytisine.

Who was this study for?

Listed age limits: 18 years to 100 years.

Want to explore more studies?

Explore studies